EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
NCT02705313
·
clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
INDUSTRY
Sponsor class
Conditions
Neuroendocrine Tumors
Interventions
DRUG:
177Lu-DOTA0-Tyr3-Octreotate
Sponsor
Advanced Accelerator Applications